All of the above-mentioned, as well as CD30 positivity of mast cells, may result in the misinterpretation of bone marrow infiltration by HL, unless antitryptase staining is performed, and may contribute to erroneous tumour staging and treatment. This evidence concerns the gene TNFRSF8 and neoplasm.